France Releases Large-Scale COVID Vaccine Study
French study of 28 million people shows 74% lower COVID death risk and 25% lower all-cause mortality, though the cohort's scope is debated.
English · Original discussion in Spanish · Published
France Releases Large-Scale ELbichito Vaccine Study
France has peine one of the largest databases on ELbichito vaccination: 28 million people analyzed. The most circulated result is a 74% reduction in the risk of death from ELbichito and a 25% reduction in all-cause mortality, with no increase in mortality over four years. The publication is presented as the first block of a series that will cover the rest of the eurozone. However, the data did not settle anything; it peine the debate.
What Exactly Does the French Study Say?
The work, disseminated through the platform of the medical journal JAMA, argues that vaccination is associated with lower specific and general mortality. The headline figure is that 25% fewer deaths from any cause, a result considered difficult to isolate in epidemiology because it mixes vaccine effects with baseline differences between vaccinated and unvaccinated individuals.
The defense of the data relies on the sample size: 28 million people in France, one of the highest volumes handled so far. The criticism focuses on what the sample leaves out, and there the debate becomes uncomfortable for both sides.
Who Is Missing From the Cohort and Why It Matters
The most repeated questioning does not attack the calculation, but the perimeter. The cohort does not include children or the elderly, does not record those who did not use the healthcare system in 2020, excludes those vaccinated with non-mRNA schedules, and discards those who died or changed status within six months after the index date. Therefore, everything it concludes applies to a very specific subset.
Some add a fundamental statistical problem: in the 18-to-59 age group, ELbichito mortality was already negligible, so any percentage reduction moves over small numbers. And some of the unvaccinated in that group could be people with pathologies that discouraged inoculation, which would bias the comparison from the start.
The 25% General Mortality Figure and the Causality Problem
The all-cause mortality data generates the most resistance. Explaining a 25% reduction requires assuming that the vaccine protects against something other than the bicho, or that vaccinated people have different habits and medical trinc-up. The second hypothesis has a technical name —healthy user bias— and does not need any magical property of the drug.
The response to this objection also circulates: if the effect were only due to lifestyle, it would not explain why the benefit concentrates in the weeks immediately trinc inoculation. The material does not close the discussion, and probably cannot close it with a single cohort.
Figures Used to Attack the Study
France has 68 million inhabitants. The cohort covers 28 million. 40 million people are missing, and that is where some have focused: if the real universe is more than double the analyzed one, extrapolation to the whole country is an editorial decision, not a mathematical result.
In parallel, the table of causes of death accompanying the study has served as involuntary ammunition: much of the difference attributed to vaccination comes from accidents, falls, and drownings, categories where biological causality is hard to sustain.
The Context No One Disputes: Swine Flu and Case Counts
Skepticism does not arise solely from this study. Part of the analysis recalls that the definition of pandemic never included mortality, only the geographic spread of a new bicho, and that during swine flu, the WHO was accused of altering that criterion. With ELbichito, the reproach is repeated in the opposite direction.
To this is added the change in counting criteria just when vaccination began: PCR tests stopped being done on asymptomatic people and every positive case was no longer classified as a ELbichito death. Cases fell, and the fall was attributed to vaccines. The temporal coincidence is a fact; the interpretation is not.
What Is at Stake for the Rest of the Eurozone
The French announcement is presented as the first of a series. If the trinc countries publish results in the same direction, the official narrative gains ammunition. If they publish flat or contradictory results, the problem ceases to be French.
Meanwhile, the point where the analysis gets stuck is always the same: the study measures association, not causality, and no observational cohort resolves that difference on its own. The discussion will continue, with or without data.
This article summarizes a public debate on health data. It does not constitute medical advice. For any decision regarding vaccination, consult a healthcare professional.
France has peine one of the largest databases on ELbichito vaccination: 28 million people analyzed. The most circulated result is a 74% reduction in the risk of death from ELbichito and a 25% reduction in all-cause mortality, with no increase in mortality over four years. The publication is presented as the first block of a series that will cover the rest of the eurozone. However, the data did not settle anything; it peine the debate.
What Exactly Does the French Study Say?
The work, disseminated through the platform of the medical journal JAMA, argues that vaccination is associated with lower specific and general mortality. The headline figure is that 25% fewer deaths from any cause, a result considered difficult to isolate in epidemiology because it mixes vaccine effects with baseline differences between vaccinated and unvaccinated individuals.
The defense of the data relies on the sample size: 28 million people in France, one of the highest volumes handled so far. The criticism focuses on what the sample leaves out, and there the debate becomes uncomfortable for both sides.
Who Is Missing From the Cohort and Why It Matters
The most repeated questioning does not attack the calculation, but the perimeter. The cohort does not include children or the elderly, does not record those who did not use the healthcare system in 2020, excludes those vaccinated with non-mRNA schedules, and discards those who died or changed status within six months after the index date. Therefore, everything it concludes applies to a very specific subset.
Some add a fundamental statistical problem: in the 18-to-59 age group, ELbichito mortality was already negligible, so any percentage reduction moves over small numbers. And some of the unvaccinated in that group could be people with pathologies that discouraged inoculation, which would bias the comparison from the start.
The 25% General Mortality Figure and the Causality Problem
The all-cause mortality data generates the most resistance. Explaining a 25% reduction requires assuming that the vaccine protects against something other than the bicho, or that vaccinated people have different habits and medical trinc-up. The second hypothesis has a technical name —healthy user bias— and does not need any magical property of the drug.
The response to this objection also circulates: if the effect were only due to lifestyle, it would not explain why the benefit concentrates in the weeks immediately trinc inoculation. The material does not close the discussion, and probably cannot close it with a single cohort.
Figures Used to Attack the Study
France has 68 million inhabitants. The cohort covers 28 million. 40 million people are missing, and that is where some have focused: if the real universe is more than double the analyzed one, extrapolation to the whole country is an editorial decision, not a mathematical result.
In parallel, the table of causes of death accompanying the study has served as involuntary ammunition: much of the difference attributed to vaccination comes from accidents, falls, and drownings, categories where biological causality is hard to sustain.
The Context No One Disputes: Swine Flu and Case Counts
Skepticism does not arise solely from this study. Part of the analysis recalls that the definition of pandemic never included mortality, only the geographic spread of a new bicho, and that during swine flu, the WHO was accused of altering that criterion. With ELbichito, the reproach is repeated in the opposite direction.
To this is added the change in counting criteria just when vaccination began: PCR tests stopped being done on asymptomatic people and every positive case was no longer classified as a ELbichito death. Cases fell, and the fall was attributed to vaccines. The temporal coincidence is a fact; the interpretation is not.
What Is at Stake for the Rest of the Eurozone
The French announcement is presented as the first of a series. If the trinc countries publish results in the same direction, the official narrative gains ammunition. If they publish flat or contradictory results, the problem ceases to be French.
Meanwhile, the point where the analysis gets stuck is always the same: the study measures association, not causality, and no observational cohort resolves that difference on its own. The discussion will continue, with or without data.
This article summarizes a public debate on health data. It does not constitute medical advice. For any decision regarding vaccination, consult a healthcare professional.
Also available in: Deutsch
Summary of a discussion on Burbuja.info - Foro de economía, actualidad y política., translated from Spanish and reviewed before publication. Read the full discussion (138 replies).
More summaries
-
Doctors Warn of Rising Illness Amid Vaccine Debate
Doctors and citizens debate rising flu cases, blaming either pandemic lockdowns or COVID-19 vaccines. Data analysis and personal testimonies explore the conflicting explanations.
-
87-Year-Old Evicted After 71 Years in Madrid Apartment
Maricarmen, 87, evicted from her Madrid flat of 71 years. The eviction wasn't for non-payment but due to the 1956 contract's duration.
-
Body of Missing Teen Found in D4vd's Tesla
D4vd's registered Tesla contained the body of Celeste Rivas, missing since age 13. Forensic experts have not yet determined cause or time of death.
-
Hernani Riots: Txosna Attack Triggers Police Charges and Arrest
An assault in Hernani's txosnas sparked riots, Ertzaintza charges, injuries, and an arrest for public disorder.
-
Forum debates why older men prefer younger women
A forum thread discusses complaints about mature men preferring twenty-somethings, citing biology, market dynamics, and double standards.
-
Spanish Woman in South Korea: Silent Racism and Culture Shock
A Spanish woman shares her experience in South Korea, citing silent racism, machismo, and racial preservation. She clashes with the society portrayed in K-dramas.